Categories: Clinical TrialEHRNews

nCartes Rolls Out REDCap Integration in Collaboration with UC Davis Medical Center

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

FREMONT, Calif., Oct. 21, 2024 /PRNewswire/ — nCartes, Inc, a leader in EHR-to-EDC clinical trial data fulfillment, has gone live with its REDCap EDC integration capability in collaboration with UC Davis Medical Center.

The nCartes vision is to transform clinical research by enabling research sites and sponsors to harness EMR data efficiently and accurately in study fulfillment.  nCartes adds the REDCap integration to its existing library of successfully installed EHR-to-EDC systems. REDCap is among the most widely used EDC systems worldwide with more than 7,000 registered institutional users in 159 countries and 2 million projects. By adding this integration, nCartes enables our customers to benefit from data quality improvement and time savings benefits on their REDCap-based studies.

“Our goal is to support customer needs across each of the industry-sponsored trials, government-sponsored trial networks, and investigator-initiated trials,” says nCartes CEO John McIlwain. “Adding the REDCap integration opens nCartes’ benefits to a large group of medical researchers who use REDCap to support their study data needs.”

The nCartes team worked closely with UC Davis Medical Center (UCDMC) under the leadership of Rachael Callcut, MD, MSPH, FACS in the roll-out of its REDCap feature. Dr. Callcut is the UCDMC Division Chief, Trauma, Acute Care Surgery and Surgical Critical Care, Chief Research Information Officer, Vice Chair Clinical Data Science, and Associate Dean of Data Science & Innovation. 

The initial nCartes-REDCap UCDMC study, called ACIT, is a trauma study designed to address gaps in clinical knowledge in massive hemorrhage treatment.  In the US, trauma is the leading cause of death for persons aged 1-45 years old.  Hemorrhage is the largest contributing factor in preventable death.  For the ACIT study, nCartes supported collection of 461 data points per study subject by leveraging data from the UCDMC EMR. As part of the data transfer, nCartes:

  • Eliminated duplicate data entry
  • Assembled similarly named labs for easy and accurate data capture
  • Automated unit conversions
  • Standardized decimal places
  • Eliminated similar-named lab results not applicable to the study
  • Automated field value calculations
  • Converted numeric source data to binary values where necessary to meet study objectives.
  • The project surpassed expectations in the level of automation and accuracy nCartes achieved.

“The integration of nCartes with REDCap marks a significant advancement in streamlining clinical research efficiency,” says Dr. Callcut.  “By working together with the nCartes team, we were able to tailor the product to accurately capture research information through automated extraction of electronic medical record data. This allowed our research team to focus their time on important patient-facing research activities, rather than being bogged down on repetitive tasks with a high risk of error in manual data extraction.”

nCartes and UCDMC are pursuing additional uses of the nCartes-REDCap capability including an expansion of the ACIT trial expected to accrue as many as 500 additional patients in a new study focused on digital biomarkers for trauma patients.

About nCartes:

nCartes, Inc. (https://ncartes.ncoup.com)  is a transformational cloud software platform provider. The nCartes platform enables clinical research sponsors and research sites to harness electronic health systems (EHRs) to automate data capture for clinical trials, patient registries, cell manufacturing and more.

CONTACT: info@ncoup.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ncartes-rolls-out-redcap-integration-in-collaboration-with-uc-davis-medical-center-302281085.html

SOURCE nCoup, Inc.

Staff

Recent Posts

GE HealthCare drives innovation in theranostics with latest technological advances

GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through…

9 hours ago

Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major…

10 hours ago

Enzon and Viskase Enter into Merger Agreement

Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined companyCRANFORD,…

10 hours ago

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people…

10 hours ago